FDA Pushes New Approach To Alzheimer's Drug Development
The U.S. Food and Drug Administration on Thursday proposed guidance for drugmakers in developing new treatments for patients in the early stages of Alzheimer's disease, part of a federal push to...To view the full article, register now.
Already a subscriber? Click here to view full article